The global primary cells market is projected to reach USD 2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the forecast period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian